U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 13.07% | 9.39% | 18.29% | -5.13% | -13.73% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.03% | -2.36% | -16.90% | -10.27% | -3.06% |
| Change in Net Operating Assets | 914.95% | 886.69% | 150.14% | 1,456.52% | -80.04% |
| Cash from Operations | 71.18% | 50.27% | 34.89% | -14.62% | -120.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -75.09% | -76.68% | -76.12% | -88.50% | 57.15% |
| Total Debt Repaid | 47.02% | -0.95% | -13.91% | -18.13% | -10.15% |
| Issuance of Common Stock | -69.09% | 520.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -74.92% | -47.52% | -47.45% | -66.40% | 116.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -263.64% | 99.80% | -733.33% | -203.92% | 12.37% |
